Practical evaluation of SCr and uric acid variation for hepatitis C virus infection using a telaprevir

Practical evaluation of SCr and uric acid variation for hepatitis C virus infection using a telaprevir - Practical evaluation of SCr and uric acid variation for hepatitis C virus infection using a telaprevir

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011394

Enrollment

Registered

2013-09-01

Start date

2013-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic hepatitis C infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients of hepatitis C infection who treat telaprevir/peginterferon/ribavirin

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
case-control study	—

Countries

Japan

Contacts

Public ContactKatsuomi matsui

St. Marianna University School of Medicine, Kanagawa, Japan Department of Nephrology and Hypertension, Internal Medicine

m.katsuomi@marianna-u.ac.jp0449778111

Outcome results